Wednesday, April 26, 2023 1:27:36 PM
BY Reuters
— 8:19 AM ET 04/26/2023
April 26 (Reuters) - Boston Scientific Corp (BSX) raised its full-year profit forecast on Wednesday, after strong sales in its cardiovascular devices unit helped the company beat first-quarter estimates.
As the pandemic-induced staffing shortages ease, hospital operators have begun to see a much-awaited recovery in elective surgeries, boosting the demand for medical devices, such as the pacemakers, stents and catheters the company makes.
While analysts were expecting good results stemming from a recovery in medical procedures and product momentum, "this result well exceeded our expectations", J.P.Morgan analyst Robbie Marcus wrote in a note.
------------------------------
Highlighted area relevant to SWAV wether or not buy out occurs
Kiwi
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM